Design and in silico screening of inhibitors of the cholera toxin

By Zhang Guangtao  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 923-938

Informa Healthcare

Access to resources Recommend Favorite

In silico fragment-based drug design

By Konteatis Zenon D  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1047-1065

Informa Healthcare

Access to resources Recommend Favorite

High-throughput and in silico screenings in drug discovery

By Phatak Sharangdhar S   Stephan Clifford C   Cavasotto Claudio N  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 947-959

Informa Healthcare

Access to resources Recommend Favorite

In silico screening strategies for novel inhibitors of parasitic diseases

By Ferreira Rafaela S   Guido Rafael VC   Andricopulo Adriano D   Oliva Glaucius  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite

In silico ADMET tools: the dawn of a new generation?

By Clark David E  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 11, 2007-11 ,pp. : 1423-1429

Informa Healthcare

Access to resources Recommend Favorite